UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006944
Receipt number R000008205
Scientific Title Randomized trial of doripenem or meropenem in the treatment of febrile neutropenia
Date of disclosure of the study information 2012/01/05
Last modified on 2022/09/28 16:01:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized trial of doripenem or meropenem in the treatment of febrile neutropenia

Acronym

Randomized trial of doripenem or meropenem in FN

Scientific Title

Randomized trial of doripenem or meropenem in the treatment of febrile neutropenia

Scientific Title:Acronym

Randomized trial of doripenem or meropenem in FN

Region

Japan


Condition

Condition

patients with febrile neutropenia

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Assessment of effectiveness and safety of doripenem or meropenem in the treatment of FN in hematological disorders

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

effectiveness at 7days after the start of treatment

Key secondary outcomes

effectiveness at 3 and 5 days after the start of treatment


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

treatment with doripenem

Interventions/Control_2

treatment with meropenem

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

fever over 38 degrees
neutrocyte less than 500/mm3
T.bil <2.0mg/dl
s-Cre<2.0mg/dl

Key exclusion criteria

allergic to carbapenem
LC
pregnant woman

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tanaka Junji

Organization

Tokyo Women's Medical University
School of medicine

Division name

Department of hematology

Zip code


Address

8-1, Kawada-cho, Shinjuku-ku, Tokyo

TEL

03-3353-8111

Email

imaiyo@dh.twmu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoichi Imai

Organization

Tokyo Women's Medical University

Division name

Department of hematology

Zip code


Address

8-1, Kawada-cho, Shinjuku-ku, Toky

TEL

03-3353-8111

Homepage URL


Email

imaiyo@dh.twmu.ac.jp


Sponsor or person

Institute

Tokyo Women's Medical University

Institute

Department

Personal name



Funding Source

Organization

Tokyo Women's Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 01 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 12 Month 24 Day

Date of IRB

2012 Year 01 Month 01 Day

Anticipated trial start date

2012 Year 01 Month 01 Day

Last follow-up date

2020 Year 01 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 12 Month 24 Day

Last modified on

2022 Year 09 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008205


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name